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Abstract
Blood screening is imperfect so Donor Health Check questionnaires (DHC) are used to defer
those whose 'behaviour' suggests disproportionate risk of Blood Borne Infection (BBI).
Taking the UK case, we compare deferment of three sub-populations with different HIV
prevalence; Men-who-have-Sex-with-Men (4.7%), black-Africans (3.7%) and 'the-general-
(heterosexual)-population' (c.0.09%) arguing that, with respect to STIs, DHCs assess risk
based on broad population-level risk-groups not behaviour. This approach relies on an
imaginative geography that distances heterosexual risk from the domestic population. Most
DHCs knowingly commit the ecological fallacy allowing population-level statistics to obscure
within-group diversity, identifying inadequately the risk posed by 'low-risk-groups'. The
disjuncture between ontological risk phenomenon (diverse sexual practice) and the
epistemological grid used to map risk (homogenized risk-groups) needs examination.
Unpacking the category 'heterosexual' would both better differentiate risk within this group
and change the relative-risk calculated for 'high-risk groups'. We call for practice-based
DHCs that more accurately assess all potential donors.
1. Introduction
During the HIV/AIDS crisis of the early 1980s bans preventing men-who-have-sex-with-men
(MSM) donating blood were introduced in many parts of the world. However, as blood-
screening technologies have improved, so calls from activists, politicians and clinicians for
the lifting of these bans have increased. Over the past decade, many countries have shifted
from indefinite deferral of MSM to time-limited deferral: New Zealand now allows MSM to
donate 5 years after their last same-sex contact; Australia, Brazil, Hungary, Japan, Argentina,
and Sweden ask MSM to wait 12 months, while South Africa operates a 6 month deferment.
In the United Kingdom (UK), a long campaign by Human Rights Organizations, the National
Union of Students, and even the Royal College of Nursing, urged reconsideration of the
blanket deferral of MSM. In 2009, the Advisory Committee on the Safety of Blood, Tissues
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recommended a change from indefinite to a 12-month deferral since last MSM contact1,
and this proposal was subsequently adopted in England, Wales and Scotland (but rejected in
Northern Ireland).
Despite this trend toward time-limited deferral, the logic applied to MSM remains little
changed because of the way prevalence is calculated and risk is imagined. Drawing on the
UK as an example of an internationally dominant paradigm this paper demonstrates the
logical inconsistencies and scientific limits of current blood donor risk evaluation. The UK
Blood Service claim their approach is based on ‘the best available scientific data’ (NHSBT
2013) but we believe there is a need to examine rigorously in what those data consist so as
to explore the degree of fit between the epistemological frameworks of measurement and
the ontological phenomena under investigation. This paper, therefore, interrogates the UK
Blood Services’ Donor Heath Check (DHC – a pre-donation questionnaire used to triage
potential donors) as it selects for two sub-populations with elevated HIV prevalence (MSM
and Black Africans)2, and their relation to a third group: ‘the general heterosexual
population’. As we will argue later, broad imaginative geographies about the location of HIV
appear to inform the mapping of risk at the population level.
While some sections of the DHC assess actual risk to donor or recipient, risk from sexual
activity is largely assumed. This requires re-thinking. Currently, risks posed by blood borne
sexual infections are mapped onto broadly defined population categories (often described
as ‘risk-groups’) and geographic regions – such as MSM vs. heterosexual, and domestic vs.
foreign – rather than onto the ontologically relevant sexual acts through which HIV,
Hepatitis and other infections diffuse. As a consequence the current approach knowingly
commits the ‘ecological fallacy’ (Robinson 1950) – making inferences about individuals
based on the groups to which they are said to belong (see Cascio and Yomtovian 2013). This
1 The definition of ‘sexual contact’ used by the UK blood service is “anal or oral sex (with or without
a condom)”.
2 ‘Black African’ is a category of the UK census that marks ethnicity (others include ‘black Caribbean’
and ‘black other’). The category is also used by the UK Health protection agency to organize
surveillance data on public and sexual health.
3applies to those assumed to present a ‘high-risk’ but also to those believed to present ‘low-
risk.’
Aligning pre-donation questionnaires to population profiles rather than to behaviors means
that current procedures fail to capture the relevant risk profiles of all would-be donors.
Furthermore, much of the epidemiological literature surrounding blood safety appears to
assume a problematic division between blood donors and recipients (Galarneau 2010) –
presenting the image of the blood donor as motivated by a fragile altruism that would not
withstand more ontologically relevant questions about sexual risk taking. In contrast, we call
for the piloting of a more practice-based pre-donation questionnaire that can identify the
high-risk donors in all population groups, that can function as a more effective self-
deferment tool and that will present ‘donors-as-potential-recipients’ with information that
is consistent with programmes promoting sexual health. More broadly, in an era of
enthusiasm for ‘big data’ (ESRC 2012: Kalil 2012), our analysis offers a timely reminder that
data are only as good as the ontological assumptions and epistemological grids used to
generate them.
2. The dominant paradigm of risk evaluation and continued controversy over deferment
policy
Recent decades have witnessed advances in the clinical screening of blood and in the
epidemiological modeling of risk, yet there remains a chance that blood will be donated
during a ‘window-period’ where viral infections cannot be detected – e.g. it takes 9 days
post exposure before Nucleic Acid Testing for HIV virus becomes effective (Wainberg et al.,
2010). Because of this limitation, pre-donation questionnaires are used to manage risk by
deselecting would-be donors whose gift is judged disproportionately risky – in particular, at
risk of containing a Blood Borne Infection (BBI). As elsewhere, the UK’s National Blood
Service (NBS) use such a questionnaire to identify would-be donors whose ‘lifestyle and
medical history’ suggests they may be more likely to have contracted a recent BBI. Potential
donors are trusted to answer truthfully a range of questions, the answers to which may lead
to their deferral (see table 1). Therefore, as Titmuss (1970: 163) observed more than 40
years ago, a core question for ensuring the safety of the blood supply is: “what particular set
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of donors?” Consequently, trust and truth-telling remain central to the work of blood
agencies around the world, because whichever questions are asked – they rely ultimately on
donor honesty. The risk arising from blood transfusion must be communicated to the public
in a simple-to-understand manner so that donors at higher risk, and with them a proportion
of BBI infected blood, can be prevented from entering the supply in the first instance. Many
DHCs are now online (see www.blood.co.uk/can-i-give-blood/donor-health-check/) meaning
opportunities for stimulating efficacious self-deferral have increased.
Until the 2011 policy review, “men who had ever had oral or anal sex with another man,
even if a condom was used” (NHSBT 2011a) were deferred indefinitely. This policy had its
roots in the fog surrounding the emergence of HIV/AIDS. In March 1981 a cluster of young
gay men in New York and California were diagnosed with Kaposi’s Sarcoma (a rare cancer
associated with much older men of Mediterranean origin) and Pneumocystis carinli
pneumonia infection (a common fungal infection of the lung which seldom develops into
pneumonia in those with a healthy immune system). By the end of 1981, these same
symptoms had been found among gay men in Europe and among injecting drug users. In
the early eighties what we now call AIDS was largely known as GRID (Gay Related Immune
Deficiency) and its etiology and mechanisms of diffusion were unclear, with some early
theories positing it was caused by an immune system compromised by the stresses of ‘gay
lifestyle’. The virus eventually called HIV was isolated in May 1983 but was not confirmed as
the cause of AIDS by the US Center for Disease Control and Prevention for almost 12
months. By this time, media speculation had helped cement the idea that AIDS was a ‘gay
plague’ and the ‘inevitable consequence’ of a ‘gay lifestyle’ (Treichler 1999). By 1989 some
1700 people had contracted HIV as a result of a contaminated blood transfusion in Britain
alone (Weinberg et al., 2002) and the blood service was accused of using ‘killer blood’.
While there is now an understanding that HIV is not confined to the MSM population the
association between HIV (and other sexually transmitted infections) and MSM has proved
hard to change (it is rarely stated that 95.3% of MSM are not living with HIV).
However, since these early moments in the AIDS crisis blood screening has improved
markedly – in the UK there have been no instances of HIV spread through blood transfusion
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These improved screening technologies have prompted a growing number of activists,
clinicians and politicians in the UK and internationally to call for revision to donor selection
policies, pointing out that they exclude MSM on the basis of their group membership rather
than any specific high-risk sexual behaviours (see Tatchell, 2008; Kerry, 2010; Wainberg et
al., 2010). Rights campaigner Peter Tatchell (2008) neatly summarised the prevailing
critique:
…a total ban…lacks scientific credibility and medical justification…[it] is based on the
ill-informed, homophobic presumption that all gay and bisexual men are "high-risk"
for HIV, regardless of their individual sexual behaviour. This is nonsense. Most gay
men do not have HIV and never [will].
Meanwhile, defenders of MSM deferral insist it is not, and never has been, homophobic
because it rests “on specific sexual behaviour (such as oral or anal sex between men) rather
than sexuality…[thus] there is… no exclusion of gay men who have never had sex with a
man, nor of women who have sex with women….”(NHSBT 2010 ). Futhermore,
epidemiological data consistently show heightened HIV prevalence within the MSM group.
Nevertheless, as a result of mounting pressure a policy review was begun in 2009.
Reporting in late 2011, it found that more sophisticated epidemiological modelling and
improved BBI detection meant that the risk presented by MSM donors was insufficiently
high to justify their continued indefinite deferral. Rather, MSM who meet the other donor
criteria should be allowed to donate 12 months after last MSM contact (SaBTO 2011). This
move from indefinite to time-limited MSM deferral follows similar changes elsewhere, and
the prevailing consensus seems to be that while remaining a keenly debated issue, deferral
policy is now more consistent across all ‘high-risk groups’ (e.g. Watkins et al. 2011, NHSBT
2011a).
We disagree. The 12-month deferral does not explicitly address the diversity of risk profiles
and continues to exclude all sexually active MSM (see Brooks 2011) irrespective of their
actual sexual practice (Cascio and Yomtovian 2013). However, while all science is situated
within society and thus cannot be separated from questions of ethics and justice (see
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emerging from the MSM group is a legacy of the mistakes in the 1980s (Caplan 2010), we do
not wish to present a ‘rights-based’ critique of deferral policy (see MCT, 2009; RCN, 2011).
Indeed, legal scholars have shown there is no clear right to donate, whereas recipients of
blood products do have a legal right not to be harmed by blood products (Franklin 2007;
SaBTO 2011). These rights are firmly anchored in European law (Committee of Ministers
2008), and the UK Consumer Protection Act 1987 (UKBTTTS 2010). Moreover, the UK Equity
Act (OPSI 2007) explicitly exempts those running blood donation facilities from the
injunction against discrimination on the basis of sexual orientation (one of the very few such
exceptions in the Act) so long as such discrimination is based on reasonable scientific
evidence. Finally, key international legal test cases have found that despite ‘detriment’ to
MSM, deferment policies are objectively ‘reasonable’ when based on science and when they
facilitate safety (MCT 2009) (our emphais).
The critical ground for blood donor selection is not rights but science: It is the ‘best scientific
evidence’ - on which donor selection is based (see NHSBT 2010, 2011a), on which selection
criteria are reviewed (SaBTO 2010, 2011), on which third sector organization assent is
secured (THT 2010), on which exceptions to the UK Equity Act explicitly depend (OPSI 2007),
on which potential donors are asked to accept deferral, and most importantly, upon which
recipients of blood products are asked to place their trust.
Given how much rests upon it, it is significant that the United States Advisory Committee on
Blood Safety and Availability (ACBSA 2010) recently declined to change permanent MSM
deferment, not because extant research provides sufficient evidence for existing policy, but
because they provide an insufficient basis on which to revise it (ACBSA 2010). In fact the
committee concluded that indefinite MSM deferral is “suboptimal in permitting some
potentially high-risk donations [from heterosexuals] while preventing some potentially low-
risk donations [from MSM]” (ACBSA 2010) and called for more research to facilitate donor
selection policies (see also MCT 2009). Certainly new data are needed in the UK as much as
the US, but we argue that researchers must first interrogate thoroughly exactly what
constitutes ‘the best scientific evidence’ and whether the population paradigm is sufficient
to capture the risk posed by all potential donors; this is not an agenda that is made explicit
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of risk evaluation needs to be unpacked because it fails to address adequately the degree of
fit between its epistemology of group-based deferment – grounded on aggregate
epidemiological data at the population level – and the ontology of actual risk – embedded in
the heterogeneous complexity of individual practice.
3. The limits of pre-donation questionnaires
Pre-donation questionnaires perform a reverse triage – attempting to prioritise the least
risky to donate. Triage is necessary because testing, although improved, remains imperfect
(e.g. mislabeling, handling and storage errors cause a small number of complications and
even deaths annually – see Germain et al 2003; Murphy et al., 2009; Brooks 2011), and
because blood services seldom have the budgets to adopt all new screening technologies
(see Forsythe & Cardigan, 2009; Simmonds et al. 2002; Weinberg et al. 2002). Triage is
context dependent; where supply is limited and demand great (as with rare blood types and
organ donation), fewer donors are rejected and screening is supplemented by detailed
review of individual medical histories. The remaining risk of ‘window-period’ donation is
subordinated to recipients’ desperate need (Forsythe & Cardigan, 2009). In situations of
more reliable supply it is expedient to defer those whose donation is assumed more likely to
test positive, as long as those categorised as ‘lower-risk’ provide sufficient blood to meet
demand (Allain & Williamson 2007).
Triage is a vital tool to manage (because it cannot eliminate) relative risk, but central to its
utility are the questions and categories used to rank potential donors. Some questions in the
UK DHC positively select for good donors (e.g. age, absence of illness etc.): Others, which
concern us here, attempt to manage risk by excluding donors thought more likely to carry a
BBI (e.g. recent tattoo, intravenous drug-use, sex with an HIV positive person). However,
both kinds of question are under-utilised with respect to gathering relevant information
about the risk posed by blood borne Sexually Transmitted Infections (STIs). Ontologically,
risk of acquiring any particular STI emerges from three connected, practice-related
variables: (1) the likelihood that one’s sexual partner(s) are carriers; (2) the type of sexual
activity undertaken; and (3) the frequency of exposure. Thus to assess accurately the risk
presented by an individual donor one would need to know some tangible information about
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number of partners, or have both been monogamous for a period? Has either engaged in a
higher risk sexual activity (e.g. unprotected receptive anal intercourse – which carries a
higher risk of HIV infection than similar vaginal intercourse), or has the donor consistently
pursued safer-sex (e.g. condoms reduce risk by 80-90% while oral sex is very unlikely to
transmit HIV infection – MCT, 2009: 176)?3
On closer inspection, it is clear that the UK DHC (like most pre-donation questionnaires)
does little to capture the interaction of these variables because it asks few ontologically
relevant questions about practice. Instead, questions are primarily designed to assign
individuals into population risk-groups that are more or less associated with BBI risk (see
also Cascio and Yomtovian 2013). It is membership of a high-risk or low-risk group (e.g.
practicing MSM/non-practicing MSM/heterosexual) and not practice per se that determines
whether a donor is deferred.4 However, the language of ‘practices and lifestyles’ so often
used to explain deferral policy to the public obfuscates the issue. Rather than identify the
absolute risk presented by an individual, the DHC as triage focuses on assigning a donor to a
risk-group (e.g. practicing MSM, commercial sex worker, migrant).
4. The limits of epidemiological modelling
The operationalization of risk behaviours, groups and contexts remains overly simplistic and
leads to sub-optimal policy. To illustrate, we compare two subsections of the UK population
with similar HIV prevalence; MSM (4.7%) and black-Africans (3.7%), and consider how
judgements of relative risk are reliant on a third group - ‘the-general-(heterosexual)-
population’ (c.0.09%) (HPA 2012, 2010a – all prevelance rates include estimates of those
living with undiagnosed HIV).
3 The qualities of the anal environment, such as concentration of CD4 cells that are targeted by HIV,
and the proximity of the anal site to the gut where initial invasion and replication occurs, explain
why anal sex is more risky (Baggaley et al 2010: Beyrer et al 2012). In HIV discordant couples the per-
act risk of anal sex is 18-times higher than for vaginal sex for the receptive partner. The infectivity
risk of unprotected receptive anal sex is estimated to be 1·4% per-act and 40·4% per-partner. The
risk of insertive only unprotected anal sex is estimated to be 21% per-partner, while that for
unprotected receptive oral sex is 0.04% per-act (Baggaley et al 2010: Beyrer et al 2012).
4 The question used to identify men as MSM conflates oral and anal sex, and ignores condom use,
monogamy and multiple partnering.
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HIV risk, the deferment policy toward each group has been markedly different. Before MSM
deferment was reduced to 12 months, African migrants were already allowed to donate
after 12 months UK residence/last sexual contact with someone from a high HIV prevalence
region. While elevated HIV prevalence attaches to the entire category the greater tolerance
to the risk presented by black-Africans (a group excluded from the recent review - SaBTO
2011: 9), can in part be explained by low supply and high demand for rare blood types:
black-Africans are courted as “VIP donors” because they are more likely to have type B-
blood and, along with others of African genetic heritage, are the only source of type U-
negative blood (NHSBT, 2011b). By comparison, the genetically diverse MSM group has no
correlation with rare blood types at a population level and so the risk/benefit calculation
behind past permanent deferral was that MSM “donor loss can be tolerated” (Allain &
Williamson, 2007). This said, type B-blood is common in the more numerous and lower-risk
Asian population, and donations from black-Africans are not restricted to those with type B
or U-negative blood (c.1 in 400), or to men (twice as many black-African women are newly
diagnosed with HIV - HPA 2012). To explain fully the past and present differential deferral
policies, one must understand the role that context plays in the constitution of ‘risk-groups’.
Because in the UK most black-Africans present late, and therefore at a more advanced
clinical stage of HIV infection (Erwin & Peters, 1999), it was assumed (until recently) that
seroconversion is predominately historical; with perhaps 68% of black-African HIV
transmission occurring outside the UK (HPA, 2008b, 2010a; SaBTO 2011). Consequently, a
12-month deferral after traveling from a region of high HIV prevalence (or sex with a partner
who has so travelled), has been deemed reasonable to avoid window-period donations.
This assessment cannot be based on any impact that assimilation into the UK milieu may
have on sexual practices per se because, we re-emphasise, the DHC does not ask questions
about actual sexual practice. Instead, the DHC simply determines whether a donor can be
connected to a risk-group or a geographic region of risk via a sexual partner (inter alia
commercial sex worker, BBI carrier, MSM, recent migrant from high-risk area). Thus, the 12-
month deferral of black-Africans appears to be based on the assumption that (unless stated
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otherwise in response to DHC questions), migrants of 12-month residence draw partners
from the lower-prevalence UK ‘general (heterosexual) population’.
By contrast the model still applied to all MSM is endemic and proximate: 82% of MSM
transmission is estimated to occur within the UK and when diagnosed, is more likely to
indicate a comparatively recent seroconversion (HPA, 2009 - although a compressed time
between exposure and diagnosis also reflects the positive uptake of STI screening by many
MSM). The contextual assumption is that, regardless of specific practice, any MSM activity
constitutes a high-risk because MSM draw partners from within a high-prevalence
population (and condoms are only 80-90% effective and infidelity is always possible – see
MCT, 2009). Consequently, population-based statistical calculi predict sexually active MSM
as at disproportionate risk of making a window-period donation. Post-2011 deferral rules
require MSM to remove themselves entirely from the context of MSM sexual relations for
12 months.
These assumptions would appear to rest on simplistic and unequal understandings of social
milieu and on a particular imaginative geography or risk. Analysis of the assumptions
underlying risk categories have not always been rigorous as Galarneau’s (2010) examination
of deferral policy deliberations in the US suggests. In the UK the DHC imagines sexual
networking to only one degree of separation, leaving questions about partners’ partners
unasked. In the case of MSM, entanglement in complex sexual networks is assumed; the
presence within 12 months of a single partner from the same population category indicates
high-risk. No questions are asked to determine an individual’s specific sexual history, and
the pursuit of safer-sex (e.g. condom use) is an irrelevance. By comparison, there is no
deferral of black-Africans who are sexually active (oral, vaginal or anal; even if a condom
was used) with other black Africans.5 Rather the category is subdivided along geographical
lines (practice remains irrelevant): risk and complexity attaches to high prevalence regions
and to those who have recently travelled from them; amongst the remainder of black
Africans, complexity beyond immediate partners, and the elevated prevalence associated
5 While this would be consistent with MSM deferral it might be regarded as racist to assess people
on the basis of ethnic categories, the eventual fate in 1991 of the permanent US deferral of Haitians
immigrants (Galarneau 2010).
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with group as a whole, is ignored. The unstated ‘imaginative geography’ informing current
deferral policy toward ‘black Africans’ is that the risk of transmission and window-period
donation can be distanced ‘over there’ to the African continent, whilst ‘over here’, the
sexual networks of heterosexual black Africans are indistinguishable from those of the
‘general population’. This fails to account for the ethnically segregated geography of
contemporary Britain (see Stillwell & Van Ham, 2010) and the probability that many people
draw partners from their immediate locality/‘community’. Furthermore, it has not been
adjusted in response to the most recent surveillance reports which use “a new method of
assigning probable country of infection”, and estimate that 52% of new heterosexual HIV
infections (57% of which were among black Africans) occurred inside the UK (HPA 2012: 7).
Policy would appear to be inconsistent, and to rest on overly simplistic geographic/risk-
group categories that explicitly elide ontologically relevant behaviours and willfully
homogenises a broad range of complex sexual networks and practices.
We do not deny that the ‘MSM population’, as currently constituted in epidemiological
surveillance data, suffers from disproportionately higher levels of HIV and other BBI’s: as
series of epidemiological studies across a range of national settings have shown (Beyrer et al
2012). But our question relates precisely to the way data are constituted. We argue that
the ‘best science’ too often relies on some circular reasoning whereby design, methods and
analysis are all structured by the logic of risk-groups. This results in a failure to collect or to
analyse key data, pre-determining that the significance of risk-groups will be confirmed. For
example, an often-cited study (Sanchez et al., 2005) defended US deferral policy using data
from a post-donation survey of 52,650 respondents linked to screening results. The findings
showed that 569 donors (1.2% of 25,168 males) were MSM who should have self-deferred.
Of these, 6% subsequently had a reactive screening compared to only 1.7% of heterosexual
men surveyed (Sanchez et al., 2005: 407-9). However, no data were collected from MSM
that distinguished between oral or anal sex, or condom use. Moreover, data on partner
numbers was confused by a failure to properly correlate ‘last MSM contact’ with ‘total
lifetime partners’, making it impossible to estimate partner numbers within any given
widow period. Meanwhile, data for heterosexual men did not indicate either partner
number or sexual practice. Finally, evidence that the crude BBI prevalence for the
heterosexual group was higher than for some MSM cohorts was ignored in favour of an
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overriding focused on the risk presented by the ‘MSM group’. For all their sophistication,
statistical models “[designed to provide]… quantitative tool(s) for blood banks to estimate
the impact of certain HIV risk behaviours on the blood supply” (Musto et al., 2008: 52, see
also Germain et al., 2003) tend to be characterized by an absence of detailed about actual
sexual activities (e.g. for Musto et al. 2008 ‘MSM’ is taken as synonymous with anal sex
while heterosexual sex is imagined as exclusively vaginal).
Even in studies where diversity within MSM is recognised the relevance of condom use is
marginalised and ultimately, diversity is subsumed in favour of reconfirming the category
‘MSM’ as high-risk (see Pathela et al 2011: Beyrer et al 2012). Furthermore, assessments of
MSM risk are always relational to those calculated for the ‘general [heterosexual]
population’. This population is too rarely disaggregated, or is disaggregated in ways that
primarily reconfirm ‘MSM’ as a high-risk group. For example, a recent study from New York
City (Pathela et al. 2011) reports a headline statistic that MSM face a 140-fold higher risk of
newly diagnosed HIV than do heterosexual men. Valid though this statistic may be, we note
it is constituted in a particular way: (1) it is geographically specific (relating to a city at the
epicenter of the disease – and not necessarily relevant elsewhere): (2) it is based upon
diagnoses of HIV rather than prevalence – and while the authors acknowledge that
heterosexuals are much less likely to seek HIV screening and therefore more likely remain
undiagnosed, no weighting is applied to the calculation to attempt to control for this: (3) It is
based on a comparison between MSM and heterosexual men – rather than between MSM
and heterosexual women; the fraction of heterosexuals biologically at higher risk via
unprotected receptive sex.
Modelled estimations of “risk associated with a particular practice” (Musto et al., 2008: 50)
emerge as rather imprecise statistical associations between risk and membership of a broad
population group. Like other devices used to map coherent sub-groups onto diverse
populations, the category MSM facilitates the search for significant patterns within large
data sets, only by simultaneously obscuring multiple other dimensions of experience and
behaviour. Whilst simplification is a necessary and reasonable component of science (see
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MCT, 2009), in this case, simplification obscures practices directly relevant to the
phenomenon in question.
The tendency in surveillance data to disaggregate inadequately broad population-level
categories produces deferral policy that over-emphasises certain variables at the expense of
others. Just because identity markers like ‘gay’ and ‘bisexual’ are now eschewed, does not
mean ‘MSM’ identifies: “…precisely the [specific] behaviour that leads to an increase in
risk…” [Emphasis added] (see Franklin, 2007: 161, NHSBT, 2010, 2011a). Rather MSM
emerges as a variable primarily denoting partner choice and says little about type of sex or
frequency of exposure (Sothern and Kesby 2011: see also Young & Meyer, 2005: 1147). The
grid of risk-groups obscures actual patterns of risk within complex and diverse human sexual
practice. Explicit discussion of practice is avoided and practices with very different risk
profiles are conflated (e.g. “oral or anal sex… even if a condom was used”) (Cascio and
Yomtovian, 2013). Individual MSM, even those engaged in low-risker activities (e.g.
monogamy and/or condom-use) remain assessed on the basis of the aggregate risk for the
MSM group as a whole.
This said, if one drills down into the recent SaBTO review, a greater appreciation of
ontological complexity is evident: it is noted (1) MSM practice can be disaggregated – e.g.
50% have only non-penetrative experience, 44.7% only one sexual partner, and only 22%
have had penetrative sex in the last 12 months (of which less than half changed partner
more than twice – SaBTO 2011: 29), and (2) “societal changes” mean “gay men are…[now]
less willing to accept being ‘lumped together’ as a single risk category irrespective of their
own sexual behavior” (ibid : 43). Nevertheless, the paradigm for risk calculation remains
unchanged: epidemiological modeling studies remain the primary tool (ibid: 45-48), and few
see an alternative to these “complex [statistical] assessments of risk” (NHSBT 2011a). We
are less convinced. To develop our critique further we depart from the usual focus on MSM,
and focus instead on the group which sits at the “center of the circle” of risk calculation
(Fisher and Schonfeld 2010; 41) but which is so rarely discussed except as the category
against which other subgroups are deemed too risky to donate.
5. Unpacking heterosexuality
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Reviewing numerous studies we were struck by how infrequently authors acknowledge
explicitly the contribution that ‘low-risk’ groups make to over-all incidence of BBIs. A careful
reading of Sanchez et al., (2005), reveals that MSM who failed to defer resulted in c.17
infected donations, whereas heterosexual donors made in excess of 400. Yet the authors
make no comment about the absolute risk presented by heterosexuals, and offer no
suggestion that deferment on the basis of some heterosexual practices might be
appropriate. The circular logic of risk-groups stands as the self-evident justification for the
paper’s focus on the minority MSM group and the argument for their continued indefinite
deferral in the USA. Similarly, while the study by Grenfell et al., (2011) disaggregates MSM
experience, it too fails to collect or compare data on risk behavior within the heterosexual
population. Meanwhile, UK statistics clearly show the greater absolute risk posed by groups
conferred ‘low risk’ status; for example: there are more heterosexuals than MSM living with
HIV (51,500 and 40,000 respectively - HPA 2012):6 in 2009 heterosexuals comprised 63% of
all new Hepatitis B cases and 54% of new HIV cases (SaBTO 2011: 20): over 70% of the 23
HIV infected blood donations detected in 2009 (England and Wales) came from
heterosexuals (HPA, 2010b). Between 1996 and 2008, of donated blood that tested positive
for any marker of infection, 44% came from donors who reported heterosexual sex as the
likely source (as opposed to 29% from MSM); crucially, 38.4% of heterosexuals that tested
positive for HIV did not report a partner that fell into any ‘high-risk’ category (SaBTO 2011:
26). Therefore, in discussions of deferral we think it important to acknowledge explicitly
Roses’ classic observation that: “a large number of people at a small risk may give rise to
more cases of disease than the small number who are a high risk [original emphasis]” (Rose,
2001 [original 1984]: 431).
However, our point is not simply that significant residual risk remains even after some of the
total risk is eliminated via the exclusion of active MSM. Rather, it is also that the existing
practice insufficiently emphasizes that accurate and efficacious measures of prevalence and
incidence are entirely reliant on the parameters used to define ‘the population’ under
investigation. As geographers with an appreciation of the ‘modifiable areal unit problem’
(Openshaw, 1984), we are acutely aware that quantitative data can yield very different
6 Although in 2011 new diagnosis were higher among MSM than heterosexuals for the first time
since 1999 and have remained at 2,300-2,500 per year for a decade (HPA 2012).
15
results depending on what spatial units and/or social categories are used to organize and
analyze it. In our view deferral policy not only knowingly commits an ‘ecological fallacy’
(Robinson, 1950) with respect to practicing MSM it also does so in relation to the general
[heterosexual] population: again risk is calculated in terms of the group as whole – except in
the latter case large group size greatly reduces an individual’s risk when expressed as a
percentage. Thus while it is too simplistic to suggest that deferral criteria construct all MSM
as ‘infected’ and others as ‘risk free’ (see Cascio and Yomtovian 2013), recognition of
absolute risk within the majority group is seldom made explicit.
The heterosexual population and heterosexual practice is in fact diverse, but it is too rarely
measured in ways that reveal this. Let us take one example to illustrate the point: anal sex
is undeniably part of the contemporary heterosexual repertoire, with c40% reporting at
least one experience, and 10% (in both UK and US studies) reporting anal sex within the last
three months (Javanbakht et al., 2010) to a year (McBride & Fortenberry, 2010). There are
indications that prevalence is increasing (Gindi et al., 2008; McBride & Fortenberry, 2010).
Meanwhile, condom usage among heterosexuals reporting anal sex tends to be low (c.60%
never use), while the same individuals are also more likely to report a history of STIs (Hensel
et al., 2010; Javanbakht et al., 2010; McBride & Fortenberry, 2010). Studies in New York
found only 38.3% of heterosexual men reported condom use at last sex compared to 62.9%
of MSM (Pathela et al 2011) while only 23% of heterosexuals used condoms during anal sex,
compared to 61% of MSM (The Body, 2010). This raises the possibility that more
heterosexuals practice un-protected anal sex (and within the last 12 months) than do MSM;
Halperin (1999 in Baggaley et al 2010) suggested a ~7-fold higher figure in the US. And yet
as previously noted, many influential models used to “estimate the impact of certain HIV
risk behaviours” (Musto et al., 2008: 52) make no assessment of such practice, conflating
heterosexual sex (including that which is transactional or involves people from high-risk
regions) with exclusively vaginal sex. Others mention the issue but offer no calculus of the
risk (Beyrer et al 2012) despite studies which have suggested that undeclared acts of
unprotected receptive anal sex may “explain why no vaginal microbicide has been proven
effective in preventing or reducing HIV acquisition” in trials among heterosexuals in sub-
Saharan Africa (McGowan and Taylor 2010: 636).
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In our teaching we are at pains to critique the ontology of population-based risk-groups,
encouraging students to deconstruct the category ‘heterosexual’ and recognise the diversity
of practices subsumed within this label (e.g. multiple and co-partnering, casual sex, anal sex,
unprotected sex, and combinations thereof - see Bell et al., 2010; Javanbakht et al., 2010;
McBride & Fortenberry, 2010). We urge our (predominately middleclass, white and
heterosexual) students to reflect on their sexual histories and connections to local/global
networks of known and unknown others. Situated as they are in an internationally diverse
community that revels in its title as ‘Britain’s top match-making university’, and which
enjoys a vigorous social scene, we suggest that like other young people, their sexual
networks are probably complex (see Berman et al., 2004; Vivancos et al., 2008), and sexual-
health risk more proximate than they assume. We remain surprised, therefore, when
mobile blood collection units visiting campus fail to encourage any real reflection on actual
practice. Both practitioners and donors trust the notion that membership of an
undifferentiated ‘heterosexual’ group indicates low-risk: heterosexuals who pursue high-
risk practices (e.g. unprotected anal sex with multiple partners) continue to donate
immediately without question. Because these arrangements provide no explicit space for an
individual who falls outside an already constituted risk group to reflect on the risk their
donation of blood may pose they cannot “encourage maximum truthfulness on the part of
donors” (cf. Titmuss 1970: 163).
So long as analysis of generalised patterns across populations remain the primary means to
assess the risk of a would-be donor, blood services should not claim to be doing all they can
to “minimize the risk of a blood transfusion transmitting an infection to patients” (NHSBT,
2010). By comparison, attending to diversity within heterosexual practice: may change the
relative-risk calculated for current ‘high-risk groups’ like MSM: would more appropriately
recognise the risks present within the majority heterosexual group: and will speak directly to
Blood Service’s insistence on vigilance to the emergence of previously unidentified
infectious agents (e.g. SaBTO 2011: 22), by recognising that the source of future threats may
not be the risks-groups mapped out by past crises.
One response to ontological diversity would be to produce more complex risk-profiles for
sub-populations of heterosexuals: so for example: HIV is geographically concentrated in
17
metropolitan areas (in the UK, particularly London – HPA 2012); the economically deprived
are more likely to contract HIV and other STI’s (HPA 2012 - HIV prevelence is 2.8% in some
poor urban areas in the US - CDC 2012); it is likely that housing insecurity has a negative
influence on STI rates (Buffardi et al., 2008); level of educational attainment is a key
indicator in heterosexual risk-taking (Leichliter et al., 2010); cohort studies suggest
correlation between excess alcohol consumption, number of sexual partners and STIs
(Standerwick et al., 2007); travel may be associated with sexual risk-taking (Bellis et al.,
2004; Mercer et al., 2007); and of course we could go on… But we are not arguing for a finer
taxonomy of ‘risk-groups’ as proxies for practice – as if only rich, white, suburban
homeowners, who have a degree, drink moderately and avoid holidays on the Costa-del-Sol
should be allowed to donate blood. Our point is that findings about relative prevalence
rates rest upon the epistemological choices we make about how to collect and categorize
STI surveillance data; these result from the questions we choose to ask, they do not have
firm ontological existence. If we chose to map STI prevalence onto populations engaging in
anal sex, or multiple partnering within a relevant ‘window-period’, we might produce very
different risk-profiles. Deferral is always about eliminating a proportion of the total risk –
the issue is whether or not existing cognitive maps of risk drawn the right lines, and whether
science can devise new means to exclude a greater proportion of the total risk – whilst
continuing to exclude the most risky fraction of currently recognized ‘high-risk’ groups?7
6. Reforming Pre-Donation Questionnaires
We have asserted elsewhere (Sothern and Kesby 2011) that the NBS could better assess
individual risk, stimulate more effective self-deferral, and (potentially) improve available
data, if it utilised a more ontologically relevant pre-donation questionnaire that explicitly
addressed sexual practice. Longstanding aversion to practice-based assessments sheds light
on the pervasiveness of the dominant population paradigm and the limits it places on
scientific understanding. In a revealingly hetero-normative statement, the Strategy Director
of the Scottish Blood Service suggested:
7 An un-named reviewer suggested that practiced-based questions might also be applicable to non-
sexual practices (e.g. have you abstained from IV drug use/only pursued safe injection - in the last 12
months). We welcome debate on this issue – though it is beyond the scope of the current paper.
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“…I think healthy, happy couples [also] have unprotected sex, [but] I think we would
have very few blood donors if we had to go into [a] detailed sexual history with
everyone who volunteered” (BBC, 2008).
We do not believe that the history of relevant practice would need to be detailed (see
below), and doubt all who fall outside existing high-risk groups should be described as
“happy-healthy-couples”. We also reject the underlying assumption that dominant
heterosexual practice presents no threat to the blood supply. Meanwhile, SaBTO defends
population-based deferment because:
‘…there is insufficient evidence… to determine the impact on blood safety of… a
system [that assesses every individual's behaviour]. It is also not certain that all people
could objectively assess their own level of risk. Based on published data, the review…
concluded that the introduction of extensive donor questions regarding sexual
behaviour could lead to a loss of existing donors who may find the process intrusive”
(NHSBT 2011a).
All three parts of this statement are problematic: first more evidence exists than SaBTO
seems willing to admit. Since 2001 Italy has operated deferment criteria based on sexual
practices, and like the UK, processes c.2.5 million donations annually from a similarly sized
national population (SaBTO 2011: 49, 67). Extrapolating figures from a 20% sample, it seems
c.650 infected donations were made in Italy 1997-2005, most from heterosexuals (ibid: 49).
By comparison, 747 infected donations were made in the UK 1996-2008 by people who
should have deferred (ibid: 28). This figure excludes infected donations from heterosexuals
with no connection to a ‘high-risk’ category and therefore no requirement to defer. When
included, a figure of 335 infected donations was recorded in 2009 alone (ibid: 335).
However, rather than explore the implications of these data, SaBTO talks down the
significance of the Italian example on the basis of the relative lack of data (ibid: 49).
Second, we agree that it is difficult to objectively assess one’s own level of risk, and that
some MSM, resentful that overly simplistic risk-group deferral categories inadequately
describe their own complex practice and circumstances, have made ineligible donations
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believing themselves to be low-risk, only to test positive for BBIs (Grenfell et al. 2011).
However, the point would be that these MSM donations, and those of a much larger
number of heterosexuals who also test positive for BBIs, are made in the absence of any
detailed questioning that might stimulate more realistic reflection and self-deferral that
would remove a greater proportion of the total risk.
Third, beyond cross referencing each other, the Blood Service (NHSBT 2011a), SaBTO (2011),
Grenfell et al., (2011) and Watkins (et al., 2011) cite only the postal questionnaire study of
Canadian blood donors by Goldman et al., (2011) as evidence for the contention that
assessing the actual behaviours of all donors would cause donation rates to fall. However,
these reports misread this study: while respondents voluntarily answered several somewhat
more detailed questions, and (males only) indicated preference level for detailed questions
on sexual behaviour, no respondents were asked directly if such questions would actually
deter donation, or whether deferral should be based on actual sexual practice. Questions
focused explicitly on MSM risk while reference to risks within the heterosexual group was
muted. Data generated were broad and consisted of uncorrelated descriptive statistics with
only limited fit to ontologies of transmission risk and BBI detection. Therefore, the papers’
conclusion that practice-based questions are “unfeasible due to large donor loss” (ibid 2011:
1834) is not informed by rigorous analysis of donor opinion; instead the paper concludes
that were data on sexual behaviour of all donors collected (using similarly unrefined
questions), whole new gross population categories of ‘high-risk’ would be identifiable,
leading (under existing protocols) to many more potential donors being deferred by blood
services themselves. Thus while the paradigmatic model offers an expedient means to
exclude a proportion of total risk by indefinitely deferring minorities like practicing MSM,
poorly differentiated population-based deferral would generate intolerable donor loss if
applied equally to broad swathes of the heterosexual population.8
8 Brooks (2011) cites a further study of attitudes towards practice-based donor assessment (Go et
al., 2011) as evidence that people “find probing questions unacceptable”. However, the study is
inconclusive since it failed to ascertain meanings behind responses (measured on a 1-7 Likert scale).
To us (and possibly respondents) the questions tested seem poorly worded and inadequately
focused on window periods or relevant risk: e.g. In the last 10 years have you… “had two or more
sexual partners in a short period of time/had a first sexual encounter with any… partners
immediately after meeting them?” [no reference to anal sex or condoms] Go et al., 2011; 743
[emphasis added]). The finding that behaviour-based questionnaires are “no more acceptable… than
20
Behavioural science and psychological studies point to blood donation as a benevolent pro-
social act in which donors gain from a sense of doing good, of social inclusion and the
knowledge that they or their loved ones may be dependent on the blood of others (Ferguson
et al., 2008; Sojka & Sojka, 2003). Indeed, thinking beyond the binary categories of ‘donor’
and ‘recipient’, it seems sensible that ‘donors-as-potential-recipients’ would want others to
be asked about risky behaviour. Indeed the study of MSM by Grenfell et al., (2011) notes
(with supporting evidence) a widespread preference for individual assessment. However,
the authors ignore the voices of their research participants and instead choose to
ventriloquize the paradigmatic position, stating without statistics or quotation: “[however
respondents]… acknowledged [that] more in-depth questioning… would be costly, complex,
and a potential deterrent to the wider donor population” (ibid 2011: 4 see also SaBTO 2011:
50).
Rather than speaking for prospective donors, we would prefer to speak with them.
Therefore we call (since SaBTO has not), for appropriately qualified social scientists to assess
public opinion toward practice-based pre-donation questionnaires rigorously, and to devise
and test bespoke questions that are brief, pertinent and not overly invasive. These need not
be complex - attempting to identify all possible risk, nor irrevocably compromised by the
inevitability of self-reporting errors - since their role would be to promote efficacious self-
deferral and exclude a proportion of total risk - leaving lab tests to identify the residual risk -
just as at present. Questions should focus on the practices most strongly associated with STI
transmission (we offer some provisional examples in table 2). It would seem sensible to test
alternative formats since questions focused on stimulating self-deferral rather than
generating useful epidemiological data might be more acceptable to the public (again see
provisional examples in table 3). It is probable that computer-based questionnaires would
generate more reliable responses than paper-based surveys or face-to-face interviews (see
Katz et al., 2007; Locke et al., 1992; O’Brien et al., 2006) and certainly, online materails
the current… questionnaire” (ibid; 750) might say as much about respondent’s views on the study’s
methodology as it does about opinions on practice-based assessments.
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could be better used to prepare donors for personal questions and to encourage effective
reflection before presenting at donation centres.
Furthermore, while we think the time has come to pilot practice-based questions we see no
reason why the strengths of this approach should not be combined with those of the
existing epidemiology and biological science, to produce a reformed DHC and deferral
process based on a broader and more robust combination of the best methods available to
science. Questions designed to correlate the most risky forms of (1) exposure (e.g.
unprotected anal sex), (2) frequency (number of partners within a given window period) and
(3) partner (derived from bio-epidemiological data) could be used to exclude a greater
proportion of the total risk across all population groups. Thus while no person would be
deferred simply on the basis of group membership, the evolving epidemiological data
(augmented with data emerging from the new DHC and, we hope, a more critically informed
approach to data categorisation) could be used to adjust practice-based deferral periods for
different categories of donor (see table 2).
Finally, we return to Titmuss’s observation that ultimately the safety of the blood supply
rests on establishing conditions and arrangements that best encourage truthfulness on the
part of all donors. Whichever questions are asked, blood services have little choice but to
trust donors to speak truthfully. Presently UK donors are trusted only to assign themselves
to population categories – but the statistics on donations testing positive for BBIs across the
full range of donors (HPA, 2010b, SaBTO 2011) suggests that this approach communicates a
deceptively simple model of risk to the public and fails to encourage adequate reflection on
actual risk behaviours thus exposing the blood supply to unnecessary risk. Furthermore,
current deferral policy drives a wedge between blood collection and broader efforts to
facilitate sexual-health education across the population as a whole (Cascio and Yomtovian
2013). This neglects that the best way to “control the determinants of incidence…[and]
lower the mean level of risk factors, [and] shift the whole distribution of exposure in a




This paper compared differential deferral policy towards three sub-groups of the UK
population as a means to expose the limits of the international paradigm of population-
based blood donor risk assessment. While screening has improved the persistence of
window periods means that pre-donation questionnaires remain an important tool in the
management of the risk of sexually transmitted Blood Borne Infections (BBI) in transfused
blood. It is important therefore that those questionnaires be evidence-based and effectively
identify the risk posed by individual donors. The paper evaluated critically what constitutes
‘the best scientific evidence’ within the existing paradigm, and found it wanting. At its heart
lies a too little acknowledged disjuncture between the ontological complexity, dynamism
and unboundedness of actual sexual practice and the epistemological simplicity and rigidity
of the categories used to estimate donor risk. Deferral policy is explained to the public in
terms of ‘lifestyles’ and ‘specific behaviours’, and yet both pre-donation questionnaires and
epidemiological models often fail to interrogate actual sexual risk-taking, doing little more
than sort donors by partner choice and divide them using simplistic imaginative geographies
that distance heterosexual risk taking. There is insufficient recognition that accurate and
efficacious measures of incidence are entirely reliant on the parameters used to define ‘the
population’ under investigation. Findings about relative BBI prevalence rates that justify the
on-going exclusion of all sexually active MSM and the acceptance of most domestic
heterosexual donors (including those form higher prevalence groups like ‘black Africans’)
irrespective of their specific sexual practices, rest upon epistemological choices about how
surveillance data are collected and categorized; they do not have firm ontological existence.
In an era of enthusiasm for ‘big data’ this paper therefore raises what we hope is a timely
question: In what do we place our trust? At present we have a system that trusts too easily
on aggregate population categories, and in donors’ willingness to assign themselves to these
despite (or without) recognition that their sexual histories are complex and individual.
Statistics show that existing deferral policy allows a significant number of infected donations
to be made annually – with heterosexuals being the major source – a practice that
introduces unnecessary risk and undermines efforts to educate the public about Sexual
health. To be authoritative, ‘the best science’ must be honest and open about its methods,
and relentlessly self-critical about the nature and limits of its claims. If there were greater
honesty about the limitations of blood screening, and specifically about the impossibility of
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filtering out all risk using population-based selection criteria, and about the likelihood of
intolerable donor loss were such aggregate deferrals applied more equally, then perhaps
the public would be more willing to trust in deferral criteria more tightly focused on the
mechanisms through which BBIs diffuse and on the test window periods that thwart
detection.
Not only is a practice-based selection policy the only way in which it is possible to treat all
potential donors equally based on probable risk, but blood-donors-as-potential-recipients
have the right to expect candour from other donors, and therefore an obligation to provide
it themselves. Rather than being a unilateral exercise in donor selection, pre-donation
questionnaires should be a bilateral opportunity for all would-be donors to reflect on the
risk their gift may pose to its recipient, and on the need to protect their own sexual health.
Taking blood from one body and injecting it into another will always carry a risk, but using
pre-donation questionnaires as a more effective tool for reflexive self-deferral, would
contribute to the public health strategy of reducing STI levels in the population as a whole,
further increasing the safety of blood transfusion.
We believe that blood donors can be trusted to see the logic of this, and despite more
relevant questioning, can be trusted to remain motivated to donate. Rather than lament the
insufficiency of data to support this view, we call for social scientists to develop questions
that are brief, pertinent and not overly intrusive, and then to test public tolerance to them
thereby informing an alternative paradigm of practice-based donor risk assessment.
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 Age <17 or > 66 (if new donor - existing donors can donate up-to 70)
 Previous donation within 12 weeks (men) or 16 weeks (women)
 Weight under 50kg
 Active cough, sore throat, or cold sore
 Pregnant or woman with baby less than 6 months old
 Taking prescribed medication (except HRT, the pill or other birth control)
Indefinite Deferral
 Woman who received a donated egg or embryo since 1980 or treated withgonadotrophin of pituitary origin or Metrodin HP
 Blood transfusion since 1980
 Family history of CJD
 Tested positive for HIV or Hepatitis C or think you may be infected with either
 Been given money or drugs for sex
 Injected illegal or non-prescribed drugs
Twelve month deferral
 Visited Malarious area
 Sex with someone who may have had sex in parts of the world where HIV is
common (including most of Africa)
 Sex with someone who has received money or drugs for sex or has injected drugs
 Man who has had oral or anal sex with another man, whether or not a
condom was used.
 Women who have had sex with a man who has had sex with another man
 Sex with someone HIV positive or who has Hepatitis B or C
Four month deferral
 Acupuncture, tattoo, piercing, or other cosmetic treatment puncturing the skin(unless performed by healthcare professional in which case seek advice)
Seek advice
 Seen doctor/dentist/healthcare professional < 7 days (other than routinescreening)
 Serious illness, seen doctor about your heart, or taken medication in past 7 days
 Contact with infectious disease or had immunizations in past 8 weeks
 Ever had hospital investigations, tests, or operations
 Been outside the UK in past 12 months
 Malaria or unexplained fever associated with travel
 Had Jaundice or Hepatitis B
 Born or lived outside the UK for 6 months or more
 Ever visited Central or South America for a period of four weeks of more.
Table 1: Summary of deferment questions used in the UK Donor Health CheckQuestionnaire www.blood.co.uk/can-i-give-blood/donor-health-check/
Opening statement:
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9 Exact length or deferral periods for different categories of donor could be adjustedregularly in light of bio-medical data and evolving epidemiological data.
While all donated blood is screened there is always the possibility that mistakes are made and
contaminated blood enters the blood supply. The first step in reducing these risks is to trust all
donors to reflect on, and to truthfully report, issues that might mean donated blood presents a
risk to recipients. You generously give blood because you know the lives it can save – including
your own or that of your loved ones – you should therefore feel reassured that all donors are
asked to answer these same questions in order to ensure the continued safety of the blood supply.
Question DeferralHave you already taken and considered the online pre-donation questionnaire Please defer until you havereviewed this document.[… question related to generic exclusion … andindefinite deferral (see table 1)…]
Do you...
Have you... Etc…
Sorry but you may not give blood
The best science suggests that we can remove some of the risk of collecting infected blood if we
ask people about both their partner group and about their actual practices. First, please identify
yourself with one of the following groups.
Man who only has sex with women (MSW)
Woman who only has sex with men (WSM)
Man who has sex with other Men (MSM) (but may also have sex with women)
Women who only has sex with women (WSW) (if you also have sex with men tick WSM)
Not sexually active (no sex in the last 12 months – regardless of usual partner type)
Sexual practice is varied and complex – so we focus below on a few practices that carry a higher
chance of exposure to a sexually transmitted infectionHave you had unprotected sex with someone in – orfrom - a region of High HIV prevalence in the last 12months If yes:All – defer (12 months)Have you had unprotected anal sex – with a new partnerin the last 12 months If yes:9MSM – defer (12 months)
 If partner (or their partner) wasblack African – defer (12months)
All women – defer (12 months)
MSW – defer (4 months)If you have had only one partner in the last 12 months -and if you have engaged in unprotected sex – is there apossibility your partner had another partner in the in thesame period.
If yes:
MSM – defer (12 months)
 If partner (or their partner) wasblack African – defer (12months)
All women – defer (12 months)
MSW – defer (4 months)
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Table 2: Some example questions for a new hybrid risk-group/practice-based DHC
Table 3: Example of a broad question format designed avoid embarrassment and tostimulate deferral but not generate good data useful to further epidemiological analysis
Question DeferralDo any other the following apply to you:
Tattoo in last 12 months
Unprotected anal sex with a new partner in thepast 12 months
Multiple partners (some without the use of acondom) in the past 4 months
Had unprotected sex in the last 4 months with apartner who may have had another partner
Had sex with someone who may have been inparts of the world where HIV is common
Had sex whilst under the influence of drugs oralcohol – and unable to recall if condoms wereused.
Visited a Malarious Area in the past 12 months
Then you should defer for 12months
